Time to Up the Standards in the Addiction Treatment World (Part II)

I believe that treatment centers should only be owned and operated by people with a medical background, or who are licensed/certified personally under the appropriate state statute.

Repealing ObamaCare Could Decimate the Addiction Treatment Industry

Should the Party of Trump succeed in repealing ObamaCare, few industries would be harder hit than addiction treatment and mental health providers.

My 2017 Wish List for Substance Use Disorder Treatment (Part I)

Everything on this year’s wish list I could have included last year, the year before that, and before I wrote Inside Rehab.

Addiction Whack-a-Mole: Why We Jump From One Fix to Another

Anecdotally, it’s not uncommon for someone who has recovered from one addiction to find himself or herself embroiled in a new problematic behavior – one that may pose a comparable threat to his or her wellbeing. How come a new fixation crops up just as a prior one is (seemingly) resolved? Several theories abound and […]

The “Tripping Cure”

Could we be on the cusp of a revolution in our field with the advent of the “tripping cure” – psychedelic-assisted psychotherapy?

Will the Magic Mushroom Help Dying Cancer Patients?

New research indicates one Psilocybin trip, lasting a mere eight hours, can reduce anxiety and depression in about 80% of cancer patients.

Rural Whites, Addiction, and Despair

According to the American Society of Addiction Medicine, opioid addiction is driving the increase in drug overdose deaths for all racial groups, but especially whites.

A New Patient-Initiated Coalition Battles Benzos

Benzodiazepines have been in widespread use for fifty years, but the clinical trials of these drugs were short-term and their long-term safety was never established.

Alternatives to Opioids for Chronic Pain: Which Ones Have Legitimacy?

Given the status quo about difficulties with opioid painkillers, how well do alternative pain approaches stand up to the scientific test?

How Low Can Pharma Go in Pushing Its Opioid Drugs?

I often equate the motives and methods of drug companies and drug cartels, but Pharma’s moral bankruptcy can surprise even me.